Clinical Trial

Vitamin D Supplementation in Breast Cancer Patients

Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
It is a randomized clinical trial aimed at exploring the neuroprotective effect of vitamin D3 (Cholecalciferol) supplementation in conjunction with paclitaxel-based chemotherapy among breast cancer patients with vitamin D insufficiency or deficiency.
Trial Details
NCT Number NCT06596122
Lead Sponsor Abdelrahman Mahmoud
Conditions Peripheral Neuropathic Pain
Enrollment 132 participants
Start Date 2024-10-15
Primary Completion 2026-11-30 (estimated)
Study Completion 2026-12-30 (estimated)
Updated on ClinicalTrials.gov 2024-09-19